STAGE III RECTAL CANCER AJCC V8
Clinical trials for STAGE III RECTAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III RECTAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III RECTAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise in shrinking HER2+ colorectal tumors before surgery
Disease control Recruiting nowThis study tests a drug called zanidatamab given before surgery to people with HER2-positive colorectal cancer. The goal is to see if the drug can shrink or eliminate tumors, making surgery more effective. About 38 adults with early-stage cancer will take part, and researchers wi…
Matched conditions: STAGE III RECTAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New scan could better reveal rectal Cancer's response to treatment
Diagnosis Recruiting nowThis early-phase study tests a special PET scan using a substance called 64Cu-M5A to see how well it shows tumor activity in people with advanced rectal cancer. About 15 participants will get the scan before and after standard chemotherapy and radiation, and the results will be c…
Matched conditions: STAGE III RECTAL CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated May 26, 2026 05:49 UTC